Efficiency analysis of multiple sclerosis therapies
At a glance
- Project leader : Anna Drewek
- Deputy of project leader : Christoph Hofer
- Project status : completed
- Funding partner : Third party
Description
In this project, various questions regarding the efficacy of approved multiple sclerosis (MS) therapies were analyzed. This included descriptive analyses of various medical metrics, as well as time-to-event models corrected for real-world biases. The analysis is based on the real-world data of NTD.